HCA Healthcare, Inc. (NYSE:HCA) Position Decreased by Baader Bank Aktiengesellschaft

Baader Bank Aktiengesellschaft decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 59.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,190 shares of the company’s stock after selling 3,171 shares during the period. Baader Bank Aktiengesellschaft’s holdings in HCA Healthcare were worth $701,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in HCA. International Assets Investment Management LLC purchased a new stake in HCA Healthcare during the fourth quarter valued at about $4,030,000. Sequoia Financial Advisors LLC lifted its stake in HCA Healthcare by 156.0% during the fourth quarter. Sequoia Financial Advisors LLC now owns 3,707 shares of the company’s stock valued at $1,004,000 after buying an additional 2,259 shares in the last quarter. Cerity Partners LLC lifted its stake in HCA Healthcare by 32.7% during the fourth quarter. Cerity Partners LLC now owns 16,819 shares of the company’s stock valued at $4,553,000 after buying an additional 4,143 shares in the last quarter. Perigon Wealth Management LLC lifted its position in shares of HCA Healthcare by 2.6% in the fourth quarter. Perigon Wealth Management LLC now owns 1,759 shares of the company’s stock worth $476,000 after purchasing an additional 44 shares in the last quarter. Finally, Louisiana State Employees Retirement System purchased a new stake in shares of HCA Healthcare in the fourth quarter worth approximately $3,248,000. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Insiders sold a total of 8,844 shares of company stock worth $3,185,932 over the last three months. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA traded up $0.31 during midday trading on Thursday, reaching $371.89. 724,637 shares of the company traded hands, compared to its average volume of 1,151,112. The firm has a market cap of $97.40 billion, a PE ratio of 18.49, a PEG ratio of 1.39 and a beta of 1.68. The stock’s 50-day simple moving average is $339.02 and its 200-day simple moving average is $327.76. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $375.64. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same period last year, the business earned $4.29 earnings per share. The business’s revenue was up 10.3% on a year-over-year basis. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 22.43 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.71%. HCA Healthcare’s dividend payout ratio is 13.16%.

Analyst Ratings Changes

A number of analysts have recently issued reports on HCA shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $335.00 price target on shares of HCA Healthcare in a research report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Oppenheimer raised their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Truist Financial raised their price objective on shares of HCA Healthcare from $375.00 to $390.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th. Finally, Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Four research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $349.28.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.